Middle East and Africa Arrythmia Monitoring Devices Market is expected to reach US$ 374.73 Mn by 2028

Atrial Fibrillation Segment to Dominate MEA Arrythmia Monitoring Devices Market during 2020–2028

According to a new market research study on “MEA Arrythmia Monitoring Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Application, and End User,” is expected to reach US$ 374.73 million by 2028 from US$ 267.07 million in 2021. The market is estimated to grow at a CAGR of 5.0% from 2021 to 2028. The report provides trends prevailing in the MEA arrythmia monitoring devices market along with the drivers and restraints pertaining to the market growth. Increase in geriatric population base is the major factor driving the growth of the MEA arrythmia monitoring devices market. However, rising cost of products and procedures hinder the growth of MEA arrythmia monitoring devices market.

The arrhythmia monitoring devices market in the Middle East and Africa comprises UAE, Saudi Arabia, South Africa, and other GCC. The COVID-19 pandemic has become the most significant challenge in the region. The Middle East has reported around 12 million cases while Africa witnessed 4.5 million cases. Many countries in the region have very less developed and underfunded healthcare systems. Sudden emergence of the virus caused severe pressure on healthcare facilities in the region. Furthermore, shortage of hospital supplies also accelerate the criticality of the condition. During the pandemic, the focus of healthcare professionals was only limited to the COVID management, which substantially hampered the number of other diagnostic procedures and elective surgeries in the region. Moreover, implementation of social distancing policies resulted into limited patients visits to cardiac centers, which drastically impacted the demand and adoption of arrhythmia monitoring devices in Middle East and Africa. Apart from this, a huge population already face a growing burden of non-communicable diseases, making them more vulnerable to the virus. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and have been unable to implement any public health measures and Iran was in deep economic recession due to the US sanctions. Such factors are restraining the growth of the market in the region. However, launch of coronavirus vaccination programs in several countries will ultimately control the situation in years to come. These efforts to control the spread will ultimately recover and restore the situations post-pandemic

The market for arrythmia monitoring devices market is segmented into type, application, end user, and country. Based on type, the market is segmented into ECG monitors, implantable monitors, holter monitors, mobile cardiac telemetry, and others. The Holter monitors segment held the largest share of the market in 2021. Based on application the arrythmia monitoring devices market is divided bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction, and others. In 2021, the atrial fibrillation segment is likely to hold the largest share of the market, however atrial fibrillation segment is expected to grow at the fastest rate during the coming years. Similarly, based on end user, the market is bifurcated into hospitals and clinics, ambulatory centers, diagnostic centers, others. The hospitals and clinics segment are likely to hold the largest share of the market in 2021, however the ambulatory centers segment is anticipated to register the highest CAGR of the market during the forecast period. 

Abbott; General Electric Company; Hill-Rom Holding Inc.; Koninklijke Philips N.V.; Medtronic; OSI Systems, Inc; are among the leading companies in the MEA arrythmia monitoring devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2019, Abbott launched new heart monitor Confirm Rx insertable cardiac monitor (ICM) for better arrhythmia detection with CE Mark in Europe and US FDA clearance. This next-generation a paperclip-sized implantable device comes with smartphone connectivity and continuous remote monitoring to track unpredictable heart rhythm problems

The report segments the MEA Arrythmia Monitoring Devices Market as follows:

MEA Arrythmia Monitoring Devices Market – By Type

• ECG Monitors
• Implantable Monitors
• Holter Monitors
• Mobile Cardiac Telemetry
• Others

MEA Arrythmia Monitoring Devices Market – By Application

• Bradycardia
• Tachycardia
• Atrial Fibrillation
• Ventricular Fibrillation
• Premature Contraction
• Others

MEA Arrythmia Monitoring Devices Market – By End User

• Hospitals and Clinics
• Ambulatory Centers
• Diagnostic Centers
• Others

MEA Arrythmia Monitoring Devices Market – By Country

• Saudi Arabia
• South Africa
• UAE
• Rest of MEA